Тreatment of adrenal insufficiency

On 24 May 2006, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 372. The active ingredient is hydrocortisone (modified release tablet) for treatment of adrenal insufficiency.